These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16565254)

  • 1. Renal manifestations in the metabolic syndrome.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.
    Heo NJ; Ahn JM; Lee TW; Chin HJ; Na KY; Chae DW; Kim S
    Hypertens Res; 2010 Jun; 33(6):573-8. PubMed ID: 20379188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
    Chen J; Gu D; Chen CS; Wu X; Hamm LL; Muntner P; Batuman V; Lee CH; Whelton PK; He J
    Nephrol Dial Transplant; 2007 Apr; 22(4):1100-6. PubMed ID: 17272313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and chronic kidney disease.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Pirulli A; Barazzoni R
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S19-23. PubMed ID: 20797564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome and chronic kidney disease.
    Peralta CA; Kurella M; Lo JC; Chertow GM
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and metabolic syndrome-related chronic kidney disease in nondiabetic, nonhypertensive adults.
    Yoon YS; Park HS; Yun KE; Kim SB
    Metabolism; 2009 Dec; 58(12):1737-42. PubMed ID: 19615700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of development of chronic kidney disease in patients with type 2 diabetes having metabolic syndrome.
    Moin S; Gondal GM; Bano U
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):472-6. PubMed ID: 18798582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification.
    Johnson DW; Armstrong K; Campbell SB; Mudge DW; Hawley CM; Coombes JS; Prins JB; Isbel NM
    Nephrology (Carlton); 2007 Aug; 12(4):391-8. PubMed ID: 17635756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of obesity and chronic kidney disease.
    Ross WR; McGill JB
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):325-35. PubMed ID: 17045219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
    Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
    Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients.
    Zalesin KC; McCullough PA
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):403-17. PubMed ID: 17045226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
    Dawood T; Schlaich MP
    Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease.
    Kwan BC; Murtaugh MA; Beddhu S
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):992-8. PubMed ID: 17702712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
    Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K
    Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
    Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
    Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.